Nutriband Inc. aksje
NTRB
$3.4900-0.1550 (-4.25%)
Laster graf...
Nutriband Inc.
Market Cap
$42,424,380
Åpning3.6100
Høy3.6900
Lav3.4186
Volum17.72k
P/EN/A
Markedsverdi42.42M
52-ukers høy11.6780
52-ukers lav3.2090
Gj.sn. volum11.13k
UtbytteN/A
Beta1.96
EPS-2.5800
Om Nutriband Inc. aksje
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate. It has a commercial development and clinical supply agreement for Aversa Fentanyl with Kindeva Drug Delivery. The company was incorporated in 2016 and is headquartered in Orlando, Florida.
Selskapsinformasjon
Børs: NasdaqCM (NCM)
Sektor: Sundhed
Industri: Bioteknologi
Adresse:
121 South Orange Avenue
32801 Orlando, United States
32801 Orlando, United States
Telefon: + 407 377 6695
Nettside: https://www.nutriband.com
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.
Laveste kursmål
15.00
↑ 329.8%
Gjennomsnittlig kursmål
15.00
↑ 329.8%
Median kursmål
15.00
↑ 329.8%
Høyeste kursmål
15.00
↑ 329.8%